TroriluzoleBHV4157, BHV-4157, BHV-4157a, FC 4157, BHV 4157
Description
Troriluzole is an orally active glutamate modulator with anticancer activity.Troriluzole enhances the expression of excitatory amino acid transporters located in glial cells and is used in the study of spinocerebellar ataxia, Alzheimer's disease, and generalized anxiety disorder (GAD).
Molecular Formula
C15H16F3N5O4S
Smiles
CN(CC(=O)NC1NC2CCC(OC(F)(F)F)CC2s1)C(=O)CNC(=O)CN
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Solubility Information
DMSO: 30 mg/mL (71.53 mM), Sonication is recommended.
Relative Density
1.518 (Predicted)